Adenike Amadi
About Adenike Amadi
Adenike Amadi is the Director and TA Lead for Global Health Economics & Outcomes Research Oncology at Bristol Myers Squibb in London, England.
Current Role as Director, TA Lead Global Health Economics & Outcomes Research Oncology
Adenike Amadi is currently serving as the Director, TA Lead Global Health Economics & Outcomes Research Oncology at Bristol Myers Squibb in London, England. In this role, Adenike is responsible for developing Global HTA & HEOR strategies focusing on payer needs for oncology indications. She leads the strategic and therapy area team for BMS oncology GI/HCC/H&N/Breast indications, and also oversees the management and development of Directors & Associate Directors within these therapy areas.
Previous Roles at Bristol Myers Squibb
Adenike Amadi's tenure at Bristol Myers Squibb includes multiple roles. She worked as Associate Director, Global Health Economics & Outcomes Research, Oncology from 2018 to 2020. Prior to that, she served as UK Health Economics & Outcomes Research Manager, Oncology from 2015 to 2018, and as UK Medical Lead & Final Signatory, Immunoscience from 2015 to 2016. She also held roles as Field Medical Advisor, Immunoscience from 2012 to 2015 and Medical Information Pharmacist, Neuroscience & Immunoscience from 2010 to 2012.
Early Career Experience at Glaxo Smith Kline Pharmaceuticals
Before joining Bristol Myers Squibb, Adenike Amadi worked at Glaxo Smith Kline Pharmaceuticals as a Medical Information Advisor, Virology & Oncology from 2009 to 2010. In this position, she provided medical information and support in the areas of virology and oncology.
Education and Academic Credentials
Adenike Amadi earned an MSc in Economic Evaluation in Healthcare from City, University of London, studying from 2013 to 2015. She also holds a Master of Pharmacy (MPharm) degree from King's College London, where she studied from 2000 to 2004. These academic credentials have equipped her with a strong foundation in pharmacy and health economics.
Leadership and Mentorship in Global Health Economics & Outcomes Research
At Bristol Myers Squibb, Adenike Amadi coaches, mentors, and develops staff within the VAP/HEOR organization. She provides cross-market payer insights into Global Access Strategies, including assessing opportunities for early access. Adenike's leadership extends to managing and developing a team of Directors & Associate Directors, ensuring they are equipped to meet the demands of the healthcare industry.